Further, the combined IL-4 and TNF-α treatment had been found to cause synergistic augmentation in PD-L1-expression in renal carcinoma cells (21) while the inductive effect of IL-1β on PD-L1-expression had been demonstrated in lung cancer and glioma cell lines (22). Here, IL4 is linked to central nervous system cancer.